NCT04437745View on ClinicalTrials.gov

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face

NACompletedINTERVENTIONAL

Enrollment

238

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

December 13, 2022

Study Completion Date

November 8, 2023

Conditions

Volume Defects in the Mid-face

Interventions

DEVICE

YVOIRE Y-Solution 720

Hyaluronic acid dermal filler

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LG Chem

INDUSTRY

NCT04437745 - To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face | Biotech Hunter | Biotech Hunter